Pascal Soriot, AstraZeneca CEO (Raphael Lafargue/Abaca/Sipa USA(Sipa via AP Images)

Covid-19 roundup: As­traZeneca launch­es 3rd US PhI­II vac­cine study with a vow to avoid 'cut­ting cor­ner­s'

As­traZeneca has launched the fi­nal round of US test­ing for their close­ly-watched Ox­ford vac­cine for Covid-19, tak­ing the third spot in line just be­hind …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.